Claims for Patent: 9,181,310

Summary for Patent: 9,181,310

Title:	Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
Abstract:	The present invention provides compositions and methods for killing or suppressing growth of Gram-negative bacteria that infect, infest or cause disease in plants, including pathogenic, saprophytic and opportunistic microbes that cause disease in plants and food borne illness in people or in animal feed.
Inventor(s):	Gabriel; Dean W. (Alachua, FL), Jiang; Yingnan (Alachua, FL)
Assignee:	University of Florida Research Foundation, Inc. (Gainesville, FL) Integrated Plant Genetics, Inc. (Gainesville, FL)
Application Number:	13/801,088
Patent Claims:	1. A transgenic plant, plant part, plant cell, or plant tissue culture comprising a DNA molecule, wherein the DNA molecule encodes a Bacterial Outer Membrane Breaching (BOMB) polypeptide sharing at least 90% amino acid identity with a BOMB polypeptide selected from the group consisting of SEQ ID NO:9, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:15, and SEQ ID NO:17. 2. The transgenic plant, plant part, plant cell, or plant tissue culture of claim 1, wherein the DNA molecule encodes a BOMB polypeptide sharing at least 95% amino acid identity with a BOMB polypeptide selected from the group consisting of SEQ ID NO:9, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:15, and SEQ ID NO:17. 3. The transgenic plant, plant part, plant cell, or plant tissue culture of claim 1, wherein the DNA encoding the BOMB polypeptide is any codon-optimized version of said DNA. 4. A method for enhancing resistance of a plant to infection or infestation by Gram-negative bacteria, said method comprising introducing into the genome of the plant an expression cassette comprising: 1) a plant promoter; 2) a gene comprising a nucleic acid sequence selected from the group consisting of (a) a nucleic acid sequence encoding a BOMB polypeptide sharing at least 90% amino acid identity with a BOMB polypeptide selected from the group consisting of SEQ ID NO:9, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:15, and SEQ ID NO:17; and (b) any codon optimized version of a nucleic acid of a sequence of (a), wherein the nucleic acid sequence is operably fused to said promoter; and 3) a plant terminator. 5. The method of claim 4, wherein the Gram-negative bacteria are pathogenic. 6. The method of claim 4, wherein the expression cassette further comprises a nucleic acid sequence encoding a secretion signal and/or an intron. 7. The method of claim 4 wherein the expression cassette further comprises an endoplasmic reticulum (ER) retention signal. 8. The method of claim 4, wherein said BOMB polypeptide is used in combination with, whether separately cloned and transformed or not, whether operably fused with or not, an additional protein, polypeptide, or peptide fragment selected from the group consisting of: (1) a nonenzymatic lytic peptide or peptide fragment, (2) an enzymatic lytic peptide or peptide fragment or protein, and (3) an enzymatic peptidoglycan degrading peptide or peptide fragment. 9. The method of claim 8, wherein the additional protein, polypeptide, or peptide fragment is selected from the group consisting of lysozymes, endolysins, proteases, chitinases, mureinolytic enzymes, enzymes with transglycosylase activity, lipases and esterases, and functional fragments thereof. 10. The plant, plant part, plant cell, or plant tissue culture of claim 3, wherein the plant is a dicot plant or a monocot plant. 11. The plant, plant part, plant cell, or plant tissue culture of claim 3, wherein the plant is selected from the group consisting of geranium plants, citrus plants, tobacco plants, and rice plants. 12. Progeny of the plant of claim 3, wherein the progeny comprises the DNA molecule encoding the BOMB polypeptide. 13. The transgenic plant, plant part, plant cell, or plant tissue culture of claim 1, wherein the DNA molecule encoding the BOMB polypeptide comprises a plant intron. 14. The transgenic plant, plant part, plant cell, or plant tissue culture of claim 1, wherein the BOMB polypeptide originates from a bacteriophage. 15. The transgenic plant, plant part, plant cell, or plant tissue culture of claim 1, wherein the BOMB polypeptide has the following properties: (a) originating from a bacteriophage; (b) lacking a bacterial secretion signal sequence; (c) lacking a functional alphahelical transmembrane domain; (d) contains a beta strand-linker-beta strand domain, wherein the domain is predicted to localize in an outer membrane of a bacterium when contacted with the bacterium; and (e) contains a globular domain. 16. The method of claim 4, wherein the BOMB polypeptide shares at least 90% or at least 95% amino acid identity with a BOMB polypeptide selected from the group consisting of SEQ ID NO:9, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:15, and SEQ ID NO:17.

Details for Patent 9,181,310

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2023-05-14
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2023-05-14
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2023-05-14